Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

LTR PHARMA FPO

Healthcare AU LTP

0.28AUD
0.005(1.82%)

Last update at 2025-06-19T06:00:00Z

Day Range

0.280.28
LowHigh

52 Week Range

0.282.15
LowHigh

Fundamentals

  • Previous Close 0.28
  • Market Cap58.82M
  • Volume308782
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.50M
  • Revenue Per Share TTM0.003
  • Gross Profit TTM 0.93M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown
Breakdown
Breakdown

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
LTP
LTR PHARMA FPO		 0.005 1.82% 0.28 - - 117.70 1.72
CSL
CSL Ltd		 -3.26 1.35% 238.71 28.85 33.67 7.67 4.14 5.94 18.44
TLX
Telix Pharmaceuticals Ltd		 -0.75 2.91% 25.00 183.21 21.01 10.96 15.11 10.80 91.38
MSB
Mesoblast Ltd		 -0.12 6.70% 1.67 - 454.55 414.37 3.34 67.90 -9.8623
NEU
Neuren Pharmaceuticals Ltd		 -0.48 3.72% 12.44 13.00 81.97 8.10 4.86 7.25 8.80

Reports Covered

Stock Research & News

View All

Profile

LTR Pharma Limited, a biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.

LTR PHARMA FPO

29/97 Creek Street, Brisbane, QLD, Australia, 4000

Key Executives

Name Title Year Born
Mr. Lee Rodne Executive Chairman NA
Mr. Jacques Schipper Chief Financial Officer NA
Mr. Peter McLennan Chief Operating Officer NA
Ms. Belinda Cleminson BEd, GIA (Cert) Company Secretary NA
Mr. Lee Rodne Executive Chairman NA
Mr. Jacques Schipper Chief Financial Officer NA
Mr. Peter McLennan Chief Operating Officer NA
Ms. Belinda Cleminson BEd, GIA (Cert) Company Secretary NA
Mr. Lee Rodne Executive Chairman NA
Mr. Jacques Schipper Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.